Dr. Matt Parker is Associate Director, Clinical Bioinformatics at Oxford Nanopore Technologies and sits in
the customer workflows (EPI2ME) team. The customer workflows team produce bioinformatics analysis
workflows and platforms (EPI2ME) for the analysis of Oxford Nanopore sequencing data. As a health care
and professionals council registered clinical bioinformatician, Matt is interested in how we can apply Oxford
Nanopore sequencing to improve human health through better genomic diagnostics. Matt and his team are
focussed on developing medical device grade analysis workflows across infectious diseases, rare disease,
and cancer that can be deployed on Oxford Nanopore devices and in the cloud to take Oxford Nanopore
sequencing reads and derive meaningful clinical interpretations.

свернуть